Table 3.
OR estimates | |||||
---|---|---|---|---|---|
Effect | Point estimate | 95% confidence limits | R 2 | p value | |
PIGD phenotype | 10.79 | 4.48 | 26.00 | 0.18 | <0.0001 |
MDS-UPDRS Bal-Gait score1 | 1.33 | 1.20 | 1.49 | 0.15 | <0.0001 |
LED2 | 1.24 | 1.14 | 1.36 | 0.14 | <0.0001 |
MDS-UPDRS motor complications score | 1.30 | 1.16 | 1.47 | 0.11 | <0.0001 |
Disease duration | 1.18 | 1.11 | 1.26 | 0.14 | <0.0001 |
Cognitive impairment3 | 3.00 | 1.51 | 5.97 | 0.05 | 0.001 |
Psychosis | 4.07 | 1.55 | 10.64 | 0.04 | 0.003 |
Urinary problems | 3.27 | 1.68 | 6.37 | 0.06 | 0.0003 |
ORs indicate the increase in odds for FOG resulting from a one-unit change in effect parameters: 1 rating point for an MDS-UPDRS rating scale score, or from 0 to 1 (effect absent to effect present), e.g., for cognitive impairment. For example, for a one-unit increase in the MDS-UPDRS Bal-Gait score, there is a 33% increase in the odds of developing freezing. 1The Balance-Gait score: the MDS-UPDRS PIGD score minus the freezing score. 2Levodopa equivalent dose (100 mg units). 3MCI or dementia.